Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Hypertension and Dizziness: is there a Relation?

https://doi.org/10.20996/1819-6446-2019-15-1-125-129

Full Text:

Abstract

One of the most frequent complaints of patients with hypertension (HT) is dizziness. Dizziness is understood as a variety of subjective sensations that patients define as “dizziness” – a sense of instability when walking, the illusion of rotation of surrounding objects, the feeling of approaching fainting, the inability to concentrate, and “fog” in the head. Experts share the systemic dizziness (vertigo) and non-systemic. The causes of vertigo in most cases are diseases of the inner ear (Meniere's disease, benign paroxysmal positional vertigo [BPPV], vestibular neuronitis. The most common form of dizziness is psychogenic dizziness. In the vast majority of cases, HT is not the cause of dizziness. The most common cause of vestibular (systemic) dizziness in patients with HT, as in the general population, is BPPV, and the most common cause of non-systemic dizziness is psychogenic dizziness. Among other causes of dizziness in patients with HT should be kept in mind too fast and/or intensive lowering of blood pressure, rhythm and conduction disorders, orthostatic hypotension (especially in elderly and senile patients in the presence of concomitant diabetes).

About the Authors

V. A. Parfenov
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

MD, PhD, Professor, Head of Chair of Nervous Diseases and Neurosurgery,

Trubetskaya ul. 8-2, Moscow, 119991



T. M. Ostroumova
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Russian Federation

MD, Post-Graduate Student, Chair of Nervous Diseases and Neurosurgery,

Trubetskaya ul. 8-2, Moscow, 119991



O. D. Ostroumova
I.M. Sechenov First Moscow State Medical University (Sechenov University); Pirogov Russian National Research Medical University
Russian Federation

MD, PhD, Professor, Chair of Clinical Pharmacology and Propaedeutics of Internal Medicine, Trubetskaya ul. 8-2, Moscow, 119991;

Head of Laboratory of Clinical Pharmacology and Pharmacotherapy, Russian Gerontology Clinical Research Center, Ostrovitianova ul. 1, Moscow, 117997 



References

1. Williams B., Mancia G., Spiering W. et al; Authors / Task Force Members. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36(10):1953-2041. doi:10.1097/HJH.0000000000001940.

2. Boytsov S.A., Balanova Y.A., Shalnova S.A. et al. Arterial hypertension among individuals of 25-64 years old: prevalence, awareness, treatment and control. By the data from ECCD. Cardiovascular Therapy and Prevention. 2014;13(4):4-14. (In Russ). doi:10.15829/1728-8800-2014-4-4-14.

3. Kearney P.M., Whelton M., Reynolds K. et al. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217-23. doi:10.1016/S0140-6736(05)17741-1.

4. Tolmacheva V.A. Causes of vertigo. Neurology, Neuropsychiatry, Psychosomatics. 2010;2(4):18-24. (In Russ.) doi:10.14412/2074-2711-2010-111.

5. Zamergrad M.V. Basic problems in the diagnosis and treatment of vestibular vertigo. Neurology, Neuropsychiatry, Psychosomatics. 2010;2(3):17-21. (In Russ.) doi:10.14412/2074-2711-2010-95.

6. Bеstuzheva N.V., Parfenov V.A., Zamergrad M.V. Benign paroxysmal positional vertigo in a female with arterial hypertension and meningioma. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2014;114(4):100-4. (In Russ.)

7. Hamann K.F. Benign paroxysmal positioning vertigo: a disease explainable by inner ear mechanics. J Otorhinolaryngol Relat Spec. 2006;68(6):329-33. doi:10.1159/000095285.

8. Hornibrook J. Benign Paroxysmal Positional Vertigo (BPPV): History, Pathophysiology, Office Treatment and Future Directions. Int J Otolaryngol. 2011;2011:835671. doi:10.1155/2011/835671

9. Jacob R.G., Furman J.M. Psychiatric consequences of vestibular dysfunction. Curr Opin Neurol. 2001;14 (1):41-6.

10. Tolmacheva V.A., Parfenov V.A. Causes of dizziness in patients with arterial hypertension and its treatment. Vrach. 2007;(4):49-53 (In Russ.)

11. Parfenov V.A., Ostroumova Т.М., Ostroumova O.D., Pavleyva E.E. Features of the clinical picture in patients of middle age with essential hypertension. Tharapeutic Archive. 2018;90(9):15-26. (In Russ.). doi:10.26442/terarkh20189091526.

12. Chimirri S, Aiello R, Mazzitello C. et al. Vertigo/dizziness as a Drugs’ adverse reaction J Pharmacol Pharmacother. 2013;4(Suppl1):S104-9. doi:10.4103/0976-500X.120969.

13. Neuhauser H.K., Lempert T. Vertigo: epidemiologic aspects. Semin Neurol. 2009;29(5):473-81. doi:10.1055/s-0029-1241043.

14. Neuhauser H.K., Radtke A., von Brevern M. et al. Burden of Dizziness and Vertigo in the Community. Arch Intern Med. 2008;168(19):2118-24. doi:10.1001/archinte.168.19.2118.

15. Bisdorff A., Bosser G., Gueguen R., Perrin P. The Epidemiology of Vertigo, Dizziness, and Unsteadiness and Its Links to Co-Morbidities. Front Neurol. 2013;4:1-7. doi:10.3389/fneur.2013.00029.

16. Putilina M.V., Baranova O.A. The results of the multicenter observational program "GLOBUS" on the study of the prevalence of vertigo and treatment schemes in outpatient clinics. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova. 2014;114(5):33-8. (In Russ.)

17. Zamergrad M.V. Age aspects of vertigo. The Neurological Journal. 2014;19(3):21-8 (In Russ.)

18. de Moraes Marchiori L.L., Melo J.J., de Figueiredo Possette F.L., Correa A.L. Comparison of Frequency of Vertigo in Elderly with And without Arterial Hypertension. Arq Int Otorrinolaringol. 2010;14(4):456-60. (In Portugal) [de Moraes Marchiori L.L., Melo J.J., de Figueiredo Possette F.L., Correa A.L. Comparação da Frequência de Queixa de Vertigem no Idoso Com e Sem Hipertensão Arterial. Intl Arch Otorhinolaryngol. 2010;14(4):456-60].

19. Al-Asadi J.N., Al-Lami Q.A. Prevalence and Risk Factors of Benign Paroxysmal Positional Vertigo among Patients with Dizziness in Basrah, Iraq. British Journal of Medicine & Medical Research. 2015;7(9):754-61. doi:10.9734/BJMMR/2015/16542.

20. Goswami A., Sultana S., Urooj S. Socio-demographic study of hypertension and its risk factors The Pharma Innovation Journal. 2017;6(12):368-72.

21. De Stefano A., Dispenza F., Suarez H. et al. A multicenter observational study on the role of comorbidities in the recurrent episodes of benign paroxysmal positional vertigo. Auris Nasus Larynx. 2014;41(1):31-6. doi:10.1016/j.anl.2013.07.007.

22. Warninghoff J.C., Bayer O., Ferrari U., Straube A. Co-morbidities of vertiginous diseases. BMC Neurology. 2009;9:29. doi:10.1186/1471-2377-9-29.


For citation:


Parfenov V.A., Ostroumova T.M., Ostroumova O.D. Hypertension and Dizziness: is there a Relation? Rational Pharmacotherapy in Cardiology. 2019;15(1):125-129. (In Russ.) https://doi.org/10.20996/1819-6446-2019-15-1-125-129

Views: 157


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)